
MPhil and PhD students under the Post-COVID-19 Skills Development and Productivity Enhancement Project (PSDPEP) have presented progress updates on critical health research at the Social Investment Fund (SIF). The presentations, held in October 2026, focused on addressing major public health challenges in Ghana, specifically targeting drug-resistant HIV and cervical cancer. This initiative is part of a broader effort to boost high-level technical skills and productivity in the country following the global pandemic.
One of the central studies highlighted during the session examined drug-resistant mutations in the HIV-1 integrase gene. As antiretroviral therapy protocols evolve, understanding how the virus adapts and develops resistance is vital for effective clinical management. The student researchers provided insights into how these specific mutations affect treatment efficacy, establishing a foundation for more personalized and effective healthcare strategies for HIV patients within the Ghanaian medical system.
The academic session also covered significant research into the immune profiles of patients suffering from cervical cancer. By analyzing the immune responses of these patients, the researchers aim to identify biological markers that could lead to improved diagnostic tools and more targeted therapies. This work is particularly urgent given the significant health burden cervical cancer places on women in Ghana and the ongoing need for locally relevant medical data to drive treatment innovations.
The PSDPEP scholarship program is designed to enhance Ghana's scientific capacity and healthcare development by supporting advanced academic research in high-priority fields. By funding these MPhil and PhD candidates, the project ensures that Ghanaian scientists can tackle complex health issues using rigorous academic methodologies. The outcomes of these studies are expected to inform future public health policies and improve overall healthcare delivery and patient outcomes across the nation.